← Open Payments lookup

ROBERT PLEYO: Open Payments

NPI 1861631384 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,126 in 15 payments from 9 companies in 2025. Trend: 2023 $3,296 · 2024 $772 · 2025 $1,126

Food & beverage: $1,126
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$270
AstraZeneca Pharmaceuticals LP3$214
Boehringer Ingelheim Pharmaceuticals, Inc.2$144
Medtronic, Inc.1$130
Amgen Inc.1$123
Novo Nordisk Inc1$122
Travere Therapeutics, Inc.1$92
Ardelyx, Inc.1$17
Novartis Pharmaceuticals Corporation1$15

Products named: JARDIANCE, SYMPLICITY G3, TAVNEOS, Ozempic, VOYXACT, JYNARQUE, LOKELMA, FARXIGA.

Industry payments across WA — which companies pay providers there.